Recent news
February 2011
Advance Market Commitment has demonstrated that ‘innovative approaches to health financing” can work, editorial says
February 2, 2011 -- The first Advance Market Commitment (AMC)—which aims to stimulate the development and delivery of vaccines to prevent pneumococcal disease—has “shown that innovative approaches to health financing can benefit both global health and pharmaceutical companies,” a Lancet Infectious Diseases editorial says. According to the editorial, Nicaragua in December 2010 became the first low-income country to launch a new pneumonia vaccine purchased by the AMC. It adds that “another 19 countries have been approved by [the Global Alliance for Vaccines and Immunizations] GAVI for rollout of the pneumococcal vaccine by the end of the 2011.” The editorial concludes that the “involvement of more manufacturers could help such programs to grow and create a competitive market to provide access to lifesaving vaccinations for more children in the poorest countries.” See the link below for more information.
